Skip to main content

CORRECTION article

Front. Microbiol., 09 August 2022
Sec. Phage Biology
Volume 13 - 2022 | https://doi.org/10.3389/fmicb.2022.953136

Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

This article is a correction to:

  1. Development of Phage Cocktails to Treat E. coli Catheter-Associated Urinary Tract Infection and Associated Biofilms

    1. Read original article
\nBelkys C. SanchezBelkys C. Sanchez1Emmaline R. HeckmannEmmaline R. Heckmann1Sabrina I. GreenSabrina I. Green1Justin R. ClarkJustin R. Clark1Heidi B. KaplanHeidi B. Kaplan2Robert F. RamigRobert F. Ramig1Kenneth L. Muldrew,,Kenneth L. Muldrew3,4,5Casey Hines-MunsonCasey Hines-Munson6Felicia Skelton,Felicia Skelton6,7Barbara W. Trautner,,&#x;Barbara W. Trautner6,8,9†Anthony W. Maresso*&#x;Anthony W. Maresso1*†
  • 1Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States
  • 2Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States
  • 3Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States
  • 4Pathology and Laboratory Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, United States
  • 5Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, United States
  • 6Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States
  • 7H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, United States
  • 8Department of Medicine and Surgery, Baylor College of Medicine, Houston, TX, United States
  • 9Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, United States

A corrigendum on
Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

by Sanchez, B. C., Heckmann, E. R., Green, S. I., Clark J. R., Kaplan H. B., Ramig R. F., Hines-Munson C, Skelton F, Trautner B. W., and Maresso A. W. (2022). Front. Microbiol. 13:796132. doi: 10.3389/fmicb.2022.796132

In the published article “Kenneth L. Muldrew” was not included as an author. The corrected Author Contributions Statement appears below.

BS, EH, and SG performed the experiments and analyzed the data. JC performed the bioinformatic analysis of depolymerase enzymes. BT, FS, KM, and CH-M arranged for the collection of clinical isolates and corresponding antibiotic sensitivity data. RR and HK contributed to the design of the study and edited the manuscript. BS designed the study and wrote the manuscript. BT and AM contributed to the design and overall major goals of the study and edited the manuscript. All authors contributed to the article and approved the submitted version.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: phage therapy, uropathogenic E. coli, multidrug-resistance, CAUTI, biofilms

Citation: Sanchez BC, Heckmann ER, Green SI, Clark JR, Kaplan HB, Ramig RF, Muldrew KL, Hines-Munson C, Skelton F, Trautner BW and Maresso AW (2022) Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms. Front. Microbiol. 13:953136. doi: 10.3389/fmicb.2022.953136

Received: 25 May 2022; Accepted: 27 June 2022;
Published: 09 August 2022.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Sanchez, Heckmann, Green, Clark, Kaplan, Ramig, Muldrew, Hines-Munson, Skelton, Trautner and Maresso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anthony W. Maresso, maresso@bcm.edu

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.